Healthcare Services

Increased funding for precision medicine is driving growth in encephalitis treatment market

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Encephalitis Treatment Market Projected To Reach By 2030?

The encephalitis treatment market size has seen strong expansion in recent years. It is anticipated to grow from $22.17 billion in 2025 to $23.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. The increase observed in the historic period can be linked to viral infection outbreaks, neurological disorder awareness, hospital icu expansion, diagnostic imaging availability, and emergency neurology care.

The encephalitis treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $29.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. Key factors contributing to this growth during the forecast period include progress in immunotherapy, the widespread adoption of rapid diagnostics, increased investments in intensive care, the susceptibility of an aging population, and enhanced funding for neurological research. Significant trends expected throughout the forecast period encompass a higher occurrence of viral and autoimmune encephalitis, expanded application of targeted antiviral treatments, an increasing need for prompt neurological diagnosis, broader intensive care protocols, and a concentrated effort on mitigating neurological complications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Encephalitis Treatment Market?

Increased investment in healthcare infrastructure is projected to fuel the expansion of the encephalitis treatment market going forward. Healthcare infrastructure refers to the integrated system of hospitals, clinics, laboratories, and medical resources, equipped with modern technology and staffed by qualified healthcare professionals, which supports the provision of essential medical services. The rise in healthcare infrastructure investment is driven by the demand for superior diagnostic capabilities, increased critical-care capacity, and enhanced access to specialized neurological services. Encephalitis treatment is highly reliant on strong healthcare infrastructure, as patients need timely diagnosis, advanced imaging, antiviral or immunotherapy administration, and supportive care in suitably equipped facilities. For instance, in May 2024, according to Office of National Statistics, a UK-based government agency, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, which contrasts with growth of 0.9% in 2022. Therefore, the escalating investment in healthcare infrastructure is a significant driver for the growth of the encephalitis treatment market.

How Is The Encephalitis Treatment Market Broken Down By Segment Categories?

The encephalitis treatment market covered in this report is segmented –

1) By Disease Type: Primary Encephalitis, Secondary Encephalitis

2) By Treatment: Antiviral Agents, Steroid Injections, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Other Treatments

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By Diagnosis: Imaging Tests, Blood Tests, Biopsy, Other Diagnosis

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Primary Encephalitis: Viral Encephalitis, Bacterial Encephalitis, Fungal Encephalitis, Parasitic Encephalitis

2) By Secondary Encephalitis: Post-Infectious Encephalitis, Autoimmune Encephalitis, Encephalitis Due To Systemic

Which Trends Are Shaping The Encephalitis Treatment Market?

Companies operating in the encephalitis treatment market are making strategic financial commitments to expedite the creation of new therapies, bolster their research and development capabilities, and expand clinical study programs. For instance, in September 2023, Arialys Therapeutics, a US-based preclinical-stage enterprise, successfully secured $58 million in seed funding. This capital is designated to advance its lead candidate, ART5803, which is engineered to treat anti-NMDA receptor encephalitis (ANRE), a prevalent form of autoimmune encephalitis. The company plans to initiate clinical trials with healthy volunteers by late 2024, followed by testing in ANRE patients in early 2025. Arialys focuses on developing precision therapies that specifically target pathogenic antibodies impacting the central nervous system.

Which Players Are Present In The Encephalitis Treatment Market Space?

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics

Get The Full Encephalitis Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Which Region Is The Leading Market For The Encephalitis Treatment Market?

North America was the largest region in the encephalitis treatment market in 2025. The regions covered in the encephalitis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Encephalitis Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Browse Through More Reports Similar to the Global Encephalitis Treatment Market 2026, By The Business Research Company

Progressive Multifocal Leukoencephalopathy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Encephalitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report

Hepatic Encephalopathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795